(XPEV) Xpeng - Overview
Sector: Consumer Cyclical | Industry: Auto Manufacturers | Exchange: NYSE (USA) | Market Cap: 15.722m USD | Total Return: -18.2% in 12m
Avg Turnover: 106M
Qual. Beats: 0
Rev. Trend: 99.1%
Qual. Beats: 1
Warnings
Interest Coverage Ratio -10.8 is critical
Altman Z'' -1.86 < 1.0 - financial distress zone
Below Avwap Earnings
Tailwinds
No distinct edge detected
XPeng Inc. (XPEV) is a Guangzhou-based manufacturer of smart electric vehicles (EVs) operating primarily in the Chinese market. The company’s portfolio includes a diverse range of sedans, SUVs, and multi-purpose vehicles (MPVs), such as the P7 series, G9, G6, and the X9 seven-seater. Beyond vehicle manufacturing, XPeng develops proprietary technology including the XOS Tianji operating system and the SEPA 2.0 platform architecture.
The company operates within the highly competitive Chinese NEV (New Energy Vehicle) sector, where vertical integration of software and hardware is a key differentiator. XPeng’s business model extends to post-sale revenue streams, including supercharging networks, technical research, and automotive financing services. The Chinese EV market remains the worlds largest by volume, driven by aggressive infrastructure expansion and government subsidies for high-tech manufacturing.
For a deeper look into the companys financial health and valuation metrics, consider reviewing the latest data on ValueRay. XPeng continues to focus on autonomous driving capabilities and powertrain efficiency to maintain its position against both domestic startups and established global automakers.
- MONA M03 and P7+ delivery volume determines near-term revenue growth trajectory
- Volkswagen strategic partnership and technology service fees improve long-term gross margins
- Advanced driver-assistance system adoption rates differentiate brand value in competitive market
- European Union trade tariffs and geopolitical tensions impact international expansion profitability
- Chinese consumer sentiment and EV price wars pressure domestic vehicle delivery margins
| Net Income: -102.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 9.75 > 1.0 |
| NWC/Revenue: 6.23% < 20% (prev 18.12%; Δ -11.89% < -1%) |
| CFO/TA 0.08 > 3% & CFO 8.26b > Net Income -102.8m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (483.7m) vs 12m ago -48.85% < -2% |
| Gross Margin: 20.14% > 18% (prev 0.15%; Δ 2.00k% > 0.5%) |
| Asset Turnover: 85.94% > 50% (prev 56.39%; Δ 29.54% > 0%) |
| Interest Coverage Ratio: -10.79 > 6 (EBITDA TTM -521.6m / Interest Expense TTM 325.4m) |
| A: 0.05 (Total Current Assets 63.3b - Total Current Liabilities 58.2b) / Total Assets 103b |
| B: -0.41 (Retained Earnings -42.8b / Total Assets 103b) |
| C: -0.04 (EBIT TTM -3.51b / Avg Total Assets 96.1b) |
| D: -0.56 (Book Value of Equity -40.9b / Total Liabilities 72.8b) |
| Altman-Z'' = -1.86 = D |
| DSRI: 1.20 (Receivables 9.16b/4.62b, Revenue 82.5b/50.1b) |
| GMI: 0.74 (GM 20.14% / 14.88%) |
| AQI: 0.91 (AQ_t 0.22 / AQ_t-1 0.24) |
| SGI: 1.65 (Revenue 82.5b / 50.1b) |
| TATA: -0.08 (NI -102.8m - CFO 8.26b) / TA 103b) |
| Beneish M = -2.77 (Cap -4..+1) = A |
As of May 30, 2026, the stock is trading at USD 16.45 with a total of 6,656,832 shares traded.
Over the past week, the price has changed by +5.25%,
over one month by +3.72%,
over three months by -6.32% and
over the past year by -18.16%.
Xpeng has received a consensus analysts rating of 4.21. Therefore, it is recommended to buy XPEV.
- StrongBuy: 14
- Buy: 7
- Hold: 6
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 24.4 | 48.6% |
Market Cap CNY = 107b (15.7b USD * 6.7791 USD.CNY)
P/E Forward = 69.9301
P/S = 0.2049
P/B = 3.5178
Revenue TTM = 82.5b CNY
EBIT TTM = -3.51b CNY
EBITDA TTM = -521.6m CNY
Long Term Debt = 6.76b CNY (from longTermDebt, last fiscal year)
Short Term Debt = 7.81b CNY (from shortTermDebt, last quarter)
Debt = 42.9b CNY (from shortLongTermDebtTotal, last quarter) + Leases 5.49b
Net Debt = 3.94b CNY (calculated: Debt 42.9b - CCE 38.9b)
Enterprise Value = 111b CNY (107b + Debt 42.9b - CCE 38.9b)
Interest Coverage Ratio = -10.79 (Ebit TTM -3.51b / Interest Expense TTM 325.4m)
EV/FCF = 22.50x (Enterprise Value 111b / FCF TTM 4.91b)
FCF Yield = 4.44% (FCF TTM 4.91b / Enterprise Value 111b)
FCF Margin = 5.95% (FCF TTM 4.91b / Revenue TTM 82.5b)
Net Margin = -0.12% (Net Income TTM -102.8m / Revenue TTM 82.5b)
Gross Margin = 20.14% ((Revenue TTM 82.5b - Cost of Revenue TTM 65.9b) / Revenue TTM)
Gross Margin QoQ = 21.31% (prev 21.31%)
Tobins Q-Ratio = 1.07 (Enterprise Value 111b / Total Assets 103b)
Interest Expense / Debt = 0.76% (Interest Expense 325.4m / Debt 42.9b)
Taxrate = 5.46% (21.8m / 399.7m)
NOPAT = -3.32b (EBIT -3.51b * (1 - 5.46%)) [loss with tax shield]
Current Ratio = 1.09 (Total Current Assets 63.3b / Total Current Liabilities 58.2b)
Debt / Equity = 1.41 (Debt 42.9b / totalStockholderEquity, last quarter 30.4b)
Debt / EBITDA = -7.56 (negative EBITDA) (Net Debt 3.94b / EBITDA -521.6m)
Debt / FCF = 0.80 (Net Debt 3.94b / FCF TTM 4.91b)
Total Stockholder Equity = 30.3b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.11% (Net Income -102.8m / Total Assets 103b)
RoE = -0.14% (Net Income TTM -102.8m / Total Stockholder Equity 73.1b)
RoCE = -4.40% (EBIT -3.51b / Capital Employed (Equity 73.1b + L.T.Debt 6.76b))
RoIC = -6.28% (negative operating profit) (NOPAT -3.32b / Invested Capital 52.9b)
WACC = 6.73% (E(107b)/V(149b) * Re(9.15%) + D(42.9b)/V(149b) * Rd(0.76%) * (1-Tc(0.05)))
Discount Rate = 9.15% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -47.74 | Cagr: -45.15%
[DCF] Terminal Value 75.44% ; FCFF base≈4.91b ; Y1≈4.93b ; Y5≈5.22b
[DCF] Fair Price = 98.94 (EV 81.3b - Net Debt 3.94b = Equity 77.3b / Shares 781.4m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.08 | # QB: 0
Revenue Correlation: 99.07 | Revenue CAGR: 64.97% | SUE: 2.82 | # QB: 1
EPS current Quarter (2026-06-30): EPS=-0.81 | Chg30d=-71.58% | Revisions=-20% | Analysts=2
EPS current Year (2026-12-31): EPS=-0.18 | Chg30d=-252.34% | Revisions=-20% | GrowthEPS=+63.3% | GrowthRev=+22.6%
EPS next Year (2027-12-31): EPS=4.71 | Chg30d=-3.53% | Revisions=-20% | GrowthEPS=+2774.5% | GrowthRev=+25.8%
[Analyst] Revisions Ratio: -20%